Summit: Navigating the Frontiers of Innovation and Value

November 6, 2019

Public Half-Day Summit 

Along with multiple efforts to define and achieve value-based care across the public and private sectors, unprecedented innovations in technology and medicine are continuously being introduced that challenge current paradigms for health care financing and delivery. During this summit, keynote speakers and panel experts explored the latest advancements and the remaining challenges in the health care value and innovation space, as well as policy solutions to support groundbreaking initiatives.

 

Summit Program

Session 1 (8:30 a.m. – 9:00 a.m.) – Keynote: Navigating the Frontiers of Innovation and Value

Mark McClellan, M.D., Ph.D.
Director and Robert J. Margolis, MD, Professor of Business, Medicine and Policy, Duke-Margolis Center for Health Policy at Duke University


Session 2 (9:00 a.m. – 9:50 a.m.) – The Value of the Patient Voice

Lisa Bo Feng, DrPH
Senior Director, Policy and Advocacy, Cystic Fibrosis Foundation

Susan dosReis, Ph.D.
Professor & Vice Chair for Research, Pharmaceutical Health Services Research, University of Maryland School of Pharmacy

Josh Seidman, Ph.D., MHS
Managing Director, Avalere Health

David Steinhorn, M.D.
Medical Director, Palliative Care | Attending Critical Care, Children’s National Medical Center

Moderator: Jennifer Bright, MPA 
President, Momentum Health Strategies


Session 3 (10:05 a.m. – 10:30 a.m.) – The Dark Side of Innovation: Biases and Blind Spots

Caterina Bulgarella, Ph.D., M.A.
Co-Founder and Managing Director, Be Thread


Session 4 (10:30 a.m. – 11:20 a.m.) – Leveraging Innovation to Drive Value

Adimika Arthur, MPH
Executive Director, HealthTech for Medicaid

Tim Wilson, CFA
Chief Financial Officer and Strategy Lead, Quil Health

Kym Martin
Business Performance Advisor, Insperity

Jodi G. Daniel, J.D., MPH
Partner, Crowell & Moring

Moderator: Sung Hee Choe, MPH
Director, FasterCures, a Center of the Milken Institute


Session 5 (11:20 a.m. – 12:10 p.m.) – Future Policy Considerations

Clay Alspach, J.D.
Principal, Leavitt Partners

Purva Rawal, Ph.D.
Principal, CapView Strategies; Adjunct Professor, Georgetown University

Moderator: Sarah J. Dash, MPH
President and Chief Executive Officer, Alliance for Health Policy


 

Agenda

8:00 – 8:30 a.m.          Registration and Light Breakfast

 

8:30 – 8:40 a.m.          Welcome and Introductions

  • Sarah J. Dash, MPH
    President and Chief Executive Officer, Alliance for Health Policy

 

8:40 – 9:00 a.m.          Keynote: Navigating the Frontiers of Innovation and Value

  • Mark McClellan, M.D., Ph.D.
    Director and Robert J. Margolis, MD, Professor of Business, Medicine and Policy, Duke Margolis Center for Health Policy; Board Member, Alliance for Health Policy

 

9:00 – 9:50 a.m.          The Value of the Patient Voice

  • Lisa Bo Feng, DrPH
    Senior Director, Policy and Advocacy, Cystic Fibrosis Foundation
  • Susan dosReis, Ph.D.
    Professor and Vice Chair for Research, Pharmaceutical Health Services Research, University of Maryland School of Pharmacy
  • Josh Seidman, Ph.D., MHS
    Managing Director, Avalere Health
  • David Steinhorn, M.D.
    Medical Director, PANDA Palliative Care Program, Division of Critical Care, Children’s National Medical Center; Professor of Pediatrics, George Washington University
  • Moderator: Jennifer Bright, MPA
    President, Momentum Health Strategies

 

 9:50 – 10:05 a.m.        Break

 

10:05 – 10:30 a.m.      The Dark Side of Innovation: Biases and Blind Spots

  • Caterina Bulgarella, Ph.D., M.A.
    Co-Founder and Managing Director, Be Thread

 

10:30 – 11:20 a.m.      Leveraging Innovation to Drive Value

  • Adimika Arthur, MPH
    Executive Director, HealthTech for Medicaid
  • Tim Wilson, CFA
    Chief Financial Officer and Strategy Lead, Quil Health
  • Kym Martin, MBA
    Business Performance Advisor, Insperity
  • Jodi G. Daniel, J.D., MPH
    Partner, Crowell & Moring
  • Moderator: Sung Hee Choe, MPH
    Director, FasterCures, a Center of the Milken Institute

 

11:20 – 12:10 p.m.      Future Policy Considerations

  • Clay Alspach, J.D.
    Principal, Leavitt Partners
  • Purva Rawal, Ph.D.
    Principal, CapView Strategies; Adjunct Professor, Georgetown University
  • Moderator: Sarah J. Dash, MPH
    President and Chief Executive Officer, Alliance for Health Policy

 

12:10 –12:15 p.m.       Closing Remarks

Event Resources

Event Resources

All materials can be found in full at the links provided.

Session 1: Keynote Discussion – “Navigating the Frontiers of Value and Innovation”

“Spread of ACOs and Value-Based Payment Models in 2019: Gauging the Impacts of Pathways to Success.” Muhlestein, D., Bleser, W. Saunders, R. et. al. Health Affairs. October 21, 2019. Available at http://allh.us/ktVB.

“Special Report: Checking Up on the Value Movement.” McDermott, M. Roth, F. and Waldo, K. McDermott Consulting. October 3, 2019. Available at http://allh.us/CHDt.

“Determining Real-World Data’s Fitness for Use and the Role of Reliability.” Duke Margolis Center for Health Policy. September 26, 2019. Available at http://allh.us/etwC.

“12 Innovations That Will Change Health Care and Medicine in the 2020s.” Time. October 25, 2018. Available at http://allh.us/98G6.

“Mapping and Connecting the Biomedical Innovation Ecosystem.” National Academies of Sciences, Engineering, and Medicine. December 17, 2017. Available at http://allh.us/pK3r.

“Disruptive Innovation: Has it Reached Buzzword Status Yet?” Newman, D. Forbes. December 6, 2016. Available at http://allh.us/3AXQ.

“Alternative Framework Model (APM) Framework.” Health Care Payment Learning & Action Network. January 12, 2016. Available at http://allh.us/4hBP.

“Interactive Infographic of Healthcare Value Strategies.” Altarum Healthcare Value Hub. Available at http://allh.us/A9Wp.

 

Session 2: The Value of the Patient Voice

“Patient-Innovators Fill Gaps that Industry Hasn’t Addressed- or Can’t.” Demonaco, H. and Von Hippel, E. STAT. July 1, 2019. Available at http://allh.us/Gr68.

“The Patient-Perspective Value Framework: Short-and Long-term Recommendations to Influence Value Assessment Methodology.” Seidman, J., Gaur, P., and Boler, C. Avalere. May 30, 2019. Available at http://allh.us/cWEG.

“Consumer Voices for Innovation Grant Program Evaluation: Final Report.” Institute for Community Health and Center for Consumer Engagement in Health Innovation. May 2019. Available at http://allh.us/893U.

“Preventing Sepsis by Reimagining Systems and Engaging Patients.” Huff, C. Health Affairs. May 2019. Available at http://allh.us/xNYc..

“Patients as Consumers.” Weil, A. Health Affairs. March 2019. Available at http://allh.us/QBGt.

“Putting Our Guard Down: Engaging Multiple Stakeholders to Define Value in Healthcare.” Mattingly, T.J., Slejko, J.F., Perfetto, E.M., and dosReis, S. Health Affairs Blog. January 2019. Available at http://allh.us/TyCR.

“Reducing Low-Value Care: Saving Money and Improving Health.” Altarum Healthcare Value Hub. November 2018. Available at http://allh.us/AcfN.

“A Next Generation Assets-Based Public Health Intervention Development Model: The Public as Innovators.” Von Hippel, C. Frontiers in Public Health. September 4, 2018. Available at http://allh.us/M7cQ.

“What Does ‘Value’ Mean in Healthcare.” Commins, J. HealthLeaders. Media. December 11, 2017. Available at http://allh.us/8gPT.

“Measuring Value Based on What Matters to Patients: A New Value Assessment Framework.” Seidman, J., Anderson, M. Masi, D., et. al. Health Affairs Blog. May 23, 2017. Available at http://allh.us/y6DG.

 

Session 3: Keynote Discussion – “The Dark Side of Innovation: Biases and Blind Spots”

“Medtech’s Quick-Fix Addiction.” Waddell, K. and Herman, B. Axios. October 5, 2019. Available at http://allh.us/48mJ.

“Building the Case for Actionable Ethics in Digital Health Research Supported by Artificial Intelligence.” Nebeker, C., Torous, J. and Ellis, R. BMC Medicine. July 17, 2019. Available at http://allh.us/dE9w.

“Mirage or Vision? Four Blind Spots at the Core of Theranos’ Failure” Bulgarella, C. Forbes. April 22, 2019. Available at http://allh.us/KBcY.

“Stealth Research: Lack of Peer-Reviewed Evidence from Healthcare Unicorns.” Cristea, E., Cahan, E., and Ioannidis, J. European Journal of Clinical Investigation. January 28, 2019. Available at http://allh.us/XgTJ.

“Six Deadly Product Mistakes of Theranos.” Jadallah, S. Medium: The Startup. November 27, 2018. Available at http://allh.us/rATB.

“Bad Blood: Secrets and Lies in a Silicon Valley Startup.” Carreyrou, J. New York: Knopf. May 21, 2018.

“6 Lessons for Corporate innovation Teams from the Downfall of Theranos.” Namdarian, S. Medium. December 17, 2018. Available at http://allh.us/4RPC.

 

Session 4: Leveraging Innovation to Drive Value

“How SDOH Will Influence the Next Wave of Health Tech Startups.” Siwicki, B. Healthcare IT News. September 30, 2019. Available at http://allh.us/4Rbj.  

“Separating Hype from Reality in Health Tech.” Altman, D. Axios. August 16, 2019. Available at http://allh.us/gm3R.

“Lisa Suennen’s 13 Rules for Healthcare Entrepreneurs.” Washburn, J. The Intellectualist. July 9, 2019. Available at http://allh.us/WPcY.

“Analysis: Why Alexa’s Bedside Manner is Bad for Health Care.” Rosenthal, E. Kaiser Health News. June 4, 2019. Available at http://allh.us/CEfc.

“Diffusion of Innovation to Improve Health Care Value: Physician-Led Care Redesign.” Johnson, P. Gupta, A., and Makary, M. Health Affairs Blog. March 14, 2019. Available at http://allh.us/3NxW.

“Advancing Interoperability, Information Sharing, and Data Access: Improving Health and Healthcare for Americans.” Grande, T., Adams, D., Marchibroda, J, et. al. Bipartisan Policy Center. February 12, 2019. Available at http://allh.us/VgaB.

“2018 Year End Funding Report: Is Digital Health in a Bubble?” Day, S. and Zweig, M. Rock Health. January 7, 2019. Available at http://allh.us/48mJ.

“Top 6 Digital Transformation Trends in Healthcare for 2019.” Newman, D. Forbes. January 3, 2019. Available at http://allh.us/ENXf.

“Your Medical Devices are Not Keeping your Health Data to Themselves.” Kravitz, D. & Allen, M. ProPublica. November 21, 2018. Available at http://allh.us/bG7r.

 “Strengthening Biopharmaceutical Innovation: The Growing Role of Corporate Venture Capital.” Teconomy Partners LLC. Prepared for PhRMA. October 2018. Available at http://allh.us/dWP4.

“TEFCA in a Nutshell.” Golder, D. Impact Advisors. January 2018. Available at http://allh.us/gqVb.

“How ‘Maintainers,’ Not ‘Innovators,’ Make the World Turn.” Bliss, L. City Lab. April 8, 2016. Available at http://allh.us/YR7w.

 

Session 5: Future Policy Considerations

“Medicare’s Shared Savings Program Results Should Have Made Headlines. It Got a ‘Collective Shrug’ Instead.” Morris, S. Stat News. October 30, 2019. Available at http://allh.us/tCjW.

“HHS Proposes Changes to Reform ‘Stark Law’ Anti-Kickback Statute.” Firth, S. MedPage Today. October 10, 2019. Available at http://allh.us/4FPU.

“FDA’s Technology Modernization Action Plan.” Food and Drug Administration. September 17, 2019. Available at http://allh.us/fYPb.

“Emerging Triage, Treat, and Transport (ET3) Model.” Centers for Medicare & Medicaid Services. September 16, 2019. Available at http://allh.us/mctH.

“Software Update: The Latest on FDA’s Pre-Cert Pilot.” Josephson, A. Mintz. July 22, 2019. Available at http://allh.us/wEMj.

“Promising Strategies for Community Service Navigation: Lessons from Health Quality Innovators.” Centers for Medicare & Medicaid Services. July 2019. Available at http://allh.us/kVmq.

“Is the 21st Century Act a Solution or a Problem?” Kaplan, R. The Regulatory Review. May 7, 2019. Available at http://allh.us/vjn3.

“Accelerating Primary Care Redesign: CMS’ Innovation Center Announces Five New Transformative Models.” Wynne, B., Pahner, K. and LaRosa, J. Health Affairs Blog. April 24, 2019. Available at http://allh.us/kDv9.

“21st Century Cures Act: Implementation Update.” Sullivan, T. Policy and Medicine. February 17, 2019. Available at http://allh.us/4Cdy.

“FDA’s New Pilot Program Encouraging Innovation.” Bowen, A. and Marshall, E. Food and Drug Law Institute. December 6, 2018. Available at http://allh.us/3mfg.

“The Future of Healthcare Innovation and Why Government Matters.” Frist, B. Forbes. November 6, 2018. Available at http://allh.us/RVjv.

“Achieving the Interoperability Promise of 21st Century Cures.” Rucker, D. Health Affairs Blog. June 19, 2018. Available at http://allh.us/B4TD.

“The Future Role of Government in Health Information Technology and Digital Health.” Marchibroda, J., White, J., Hoagland, W., et. al. Bipartisan Policy Center. February 2018. Available at http://allh.us/YNeg.

“Regulatory Explainer: FDA User Reauthorizations From 2018 to 2022.” Brennan, Z. August 2017. Available at http://allh.us/4mCB.

“Removing Barriers to Medical Innovation.” Stossel, T. National Affairs. January 4, 2017. Available at http://allh.us/YNeg.

Experts

Speakers

Session 1: Keynote Discussion – Navigating the Frontiers of Innovation and Value

Mark McClellan Duke-Margolis Center for Health Policy at Duke University, Director and Robert J. Margolis, MD, Professor of Business, Medicine and Policy

Morgan.romine@duke.edu

 

Session 2: The Value of the Patient Voice

Jennifer Bright Momentum Health Strategies, President

jennifer@momentumhealthstrategies.com

Susan dosReis University of Maryland School of Pharmacy, Professor and Vice Chair for Research, Pharmaceutical Health Services Research

sdosreis@rx.umaryland.edu

Lisa Bo Feng Cystic Fibrosis Foundation, Senior Director of Policy and Advocacy

lfeng@cff.org

Josh Seidman Avalere Health, Managing Director

jseidman@avalere.com

David Steinhorn Children’s National Medical Center, Division of Critical Care, PANDA Palliative Care Program, Medical Director; George Washington University, Professor of Pediatrics

dsteinhorn@gmail.com

 

Session 3: Keynote Discussion – The Dark Side of Innovation: Biases and Blind Spots

Caterina Bulgarella Be Thread, Co-Founder and Managing Director

cbulgarella@ethicalsystems.org

 

Session 4: Leveraging Innovation to Drive Value

Adimika Arthur HealthTech for Medicaid, Executive Director

adimika@h24m.org

Kym Martin Insperity, Business Performance Advisor

Kym.martin@insperity.com

Sung Hee Choe Faster Cures, Director

schoe@milkeninstiute.org

Jodi G. Daniel Crowell & Moring, Partner

jdaniel@crowell.com

Tim Wilson Quil Health, Chief Financial Officer and Strategy Lead

twilson@quilhealth.com

 

Session 5: Future Policy Considerations

Clay Alspach Leavitt Partners, Principal

Clay.alspach@leavittpartners.com

Purva Rawal CapView Strategies, Principal; Georgetown University, Adjunct Professor

Purva.Rawal@capviewstrategies.com

 

 

Experts and Analysts

Edo Banach National Hospice and Palliative Care Organization, President & CEO

ebanach@nhpco.org

Deep Banerjee S&P Global Ratings, Lead Analyst

shiladitya.banerjee@spglobal.com

Julie Barnes Maverick Health Policy, Principal and Founder

julie.barnes7@gmail.com

Otis Brawley Johns Hopkins University, Bloomberg Distinguished Professor of Oncology and Epidemiology

otis.brawley@jhu.edu

Mandy Cohen North Carolina Department of Health and Human Services, Secretary

Mandy.cohen@dhhs.nc.gov

Russ Dexter Community Health Center Association of Connecticut, Chief Innovation Officer

rdexter@chcact.org

Esther Krofah Faster Cures, Senior Director

ekrofah@fastercures.org

Rena Conti Boston University Institute for Health System Innovation and Policy, Associate Research Director of Biopharma and Public Policy

rconti@bu.edu

Paul Cotton National Committee for Quality Assurance, Director of Federal Affairs

cotton@ncqa.org

Sarah Emond Institute for Clinical and Economic Review, Executive Vice President and COO

semond@icer-review.org

Lisa Fitzpatrick Grapevine Health, Founder and Chief Executive Officer

Lisa.fitzpatrick@grapevinehealth.co

Kate Goodrich CMS, Director and Chief Medical Officer, Center for Clinical Standards and Quality

Kate.goodrich@cms.hhs.gov

Len Nichols George Mason University, Director of the Center for Health Policy Research and Ethics

lnichol9@gmu.edu

Carol Regan Community Catalyst, Senior Advisor for Center for Consumer Engagement in Health

cregan@communitycatalyst.org

Lisa Suennen Manatt Digital and Technology, Group Leader

lsuennen@manatt.com